Heghine Khachatryan: Hemostasis at the Crossroads of Thrombosis and Bleeding
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared Haemophilia Foundation Australia’s post on LinkedIn, adding:
“Hemostasis is far more than the cessation of bleeding – it is a finely regulated biological equilibrium between procoagulant and anticoagulant mechanisms.
Disruption of this balance may manifest as either hemorrhagic complications or thrombotic disease, emphasizing the complexity of modern hemostasis.
Contemporary research increasingly highlights the intimate interplay between coagulation, inflammation, endothelial function, and immune responses, giving rise to the concept of immunothrombosis and reinforcing the multidisciplinary nature of thrombosis research.
These advances continue to reshape diagnostic algorithms, risk stratification, and therapeutic strategies across numerous clinical disciplines.
Continuous scientific collaboration, evidence-based practice, and translational research remain fundamental to improving outcomes for patients with bleeding and thrombotic disorders.”
Haemophilia Foundation Australia shared a post on LinkedIn:
“Currently most gene therapy for haemophilia uses gene transfer.
This involves delivering a functional gene into the body using a vector that carries it into the target cells.
This vector is often a modified virus called adeno-associated virus (AAV) made safe to use.
Once inside the body, the working gene gives instructions to liver cells to produce the missing clotting factor, which may reduce or stop bleeding episodes (‘bleeds’).
Learn more in the new Gene Therapy fact sheet.
Gene therapy is currently only available in Australia through clinical trials.
Gene therapy for haemophilia B is currently being evaluated by the Australian Government for funding to become available for Australians and we look forward to the outcome.”
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026